If interested and qualified, please include Req #2015-011 in the subject line when emailing resume tocareers@InotekPharma.com.
Position Summary
This person will lead the development and rollout of corporate branding messages across multiple communications channels and platforms.
Responsibilities
- Ability to develop a communication strategy, key messages and tactical execution plans.
- Ability to write, review and edit documents, applying universal grammatical and editorial rules and standards as well as the company’s standards. Ability to distill complex language into easy-to-understand, grammatically correct language in an active voice and to quickly synthesize information from a variety of sources (internal and external) into one effective output.
- Write, with little or no supervision, articulate, persuasive documents that compel the reader to think or act differently.
- See all angles and versatility to address many different audiences; position messages appropriately to influence broader opportunities.
- Ability to develop and leverage internal and external thought leader and advocate relationships to reinforce the company's messages, support products and market position, and promote ongoing relationship building and management.
- Ability to recognize key data points, plan for and anticipate questions and conduct interviews to elicit/probe for appropriate information.
- Ability to prepare and probe for information and apply reporting and facilitation techniques.
- Technical knowledge of production process for the development of communication collateral materials.
- Ability to identify and analyze business and audience needs to deliver messages via the most appropriate mix of media and channels as well as understand channels and vehicles available internally and externally.
- Ability to counsel on regulatory requirements relevant to communication about and promotion of products.
- Partner successfully with investor relations to ensure consistency of messages to external audiences including media and financial world
Minimum Qualifications
- Bachelors degree in public relations, communications, journalism or related field
- Experience working in-house or within a PR agency
- Proven ability to create and build a company brand and oversee Corporate Communications activities including Annual Report and Annual Meeting
- 5 years of industry experience in Biotechnology, pharmaceutical or healthcare product public relations
- Policy experience or crisis management experience are highly desirable
- Strong oral and presentation skills; expert skills in PowerPoint
- Ability to negotiate and persuade
- Superior writing skills and proven media relations skills that are results-oriented
- Strategic and creative thinker with ability to develop actionable programs that integrate soundly with business objectives
- Ability to work on multiple projects simultaneously
- Ability to productively navigate a challenging and dynamic environment, and deal with rapidly changing priorities
- Ability to interact with all levels of management and vendors
- Ability to think quickly, analytically and creatively to accommodate a dynamic communications environment
- Excellent interpersonal skills; enthusiastic, team player and self-starter; serious commitment to hard work and excellence
- Healthcare Industry experience required, preferably with specific experience working with the scientific communications; mix of agency and corporate experience preferred.
- Experience and/or knowledge of multiple communications tools, including; web-based videos and social media.
If interested and qualified, please include Req #2015-011 in the subject line when emailing resume tocareers@InotekPharma.com.
Competencies
- Adaptability / Perseverance– The ability to adapt to working effectively within a variety of situations; adapts enthusiastically to organizational change and to changes in job demands. Shows initiative and demonstrates learning orientation and flexibility. Pursues tasks with energy, drive and enthusiasm, even in the face of adversity.
- Communication and Teamwork– The ability to effectively express ideas in written, visual, and oral context. The ability to work co-operatively with others; the genuine desire to be a part of a team and contribute to organizational and team goals.
- Creativity/Innovation - creating a boundary-less environment that fosters curiosity and taking risks, openness to new approaches, diversity of new thought, blank page creativity and opportunistic thinking.
- Job Knowledge– Achieves and maintains technical and professional proficiency related to current job position and areas of expertise.
- Passion - create an exciting environment where there is the passion of academia with the discipline of industry where there is true intellectual exchange and ideas are challenged effectively.
- Results Orientation / Productive Work Habits– Drives issues to closure and gets the job done. Skilled at analyzing scope of work, as well as planning and executing a successful outcome. Understands and assigns / utilizes resources effectively and efficiently.
Company Overview
Inotek Pharmaceuticals is a clinical-stage, publicly traded, biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. Our common stock is listed on the NASDAQ Global Market under the symbol "ITEK."
Glaucoma is a disease of the eye that is typically characterized by structural evidence of optic nerve damage, vision loss and consistently elevated intraocular pressure, or IOP. Our lead product candidate, trabodenoson, is a first-in-class selective adenosine mimetic.
This molecule was developed to selectively stimulate a specific adenosine subreceptor, and was developed initially to prevent apoptosis following ischemia-reperfusion injuries such as stroke or myocardial infarction. In the eye, stimulation of this same receptor has the effect of augmenting the intrinsic function of the eye's trabecular meshwork, or TM, which is the main passageway for transporting the aqueous humor, a liquid that maintains the eye's shape and typically experiences elevated pressure in glaucoma. We believe that by enhancing this naturally occurring TM process, rather than changing the fundamental dynamics of pressure regulation in the eye, trabodenoson's mechanism of action should result in a lower risk of unintended side effects and long term safety or tolerability issues. Additionally, trabodenoson's unique mechanism of action in the TM should complement the activity of existing products that lower IOP by addressing different parts of the in-flow and out-flow system of the eye.
Trabodenoson has completed Phase 2 clinical development in primary open-angle glaucoma (POAG) and ocular hypertensive (OHT) patients and is ready for Phase 3. Trabodenoson, if ultimately approved by regulatory agencies, will be a valuable, innovative product that ophthalmologists can use alone or in combination with other approved medicines for glaucoma, and would also be a new treatment option for those patients who are refractory to current drug therapies.
The neuroprotective potential of trabodenoson is supported by the basic biology of adenosine, which has shown that stimulation of the A1 receptor by endogenous adenosine protects tissues of the central nervous system. A pre-clinical study of the impact of high IOP on retinal ganglion cells showed that trabodenoson could protect this key population of cells in the retina that, when lost, results in the irreversible vision loss. A preclinical program investigating a number of currently untreatable degenerative retinal diseases that would benefit from the neuroprotective action of trabodenoson is ongoing with the goal of supporting proof-of-concept clinical trials.
Inotek, in addition to having built a potential first-in-class ophthalmic product candidate in trabodenoson, has an experienced management team with a track record of multiple successful NDA approvals and successful product launches. Inotek intends to advance its programs through regulatory approval and to market its ophthalmology products, a specialty area, with a relatively small and focused sales and marketing team. The Company is based in Lexington, MA.
For more information, please visit www.InotekPharma.com
If interested and qualified, please include Req #2015-011 in the subject line when emailing resume tocareers@InotekPharma.com.
Inotek Pharmaceuticals Corporation is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.
